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Abstract
Background: Carcinoma of the prostate metastasising to the penis is rare. These patients have a
poor prognosis receiving various treatment modalities.
Case presentation: Two such patients are discussed here having received differing therapeutic
regimes, pointing out the necessity for standardised palliative treatment rather than radical therapy.
Conclusion: Management of patients with penile metastases from carcinoma of the prostate
should emphasise improving quality of life with palliative treatment rather than radical therapy
Introduction
Metastasis to the penis is rare, despite rich vascularisation
and complex circulation. These most commonly arise
from the prostate and the bladder [1,2]. It is a debilitating
near terminal condition at presentation with a dismal
prognosis. Conservative management is generally advo-
cated with emphasis on improvement of quality of life.
Therapeutic modalities used include radical penile ampu-
tation and radical radiotherapy. We discuss two patients
who underwent differing treatment; the presenting fea-
tures and symptomatology of all other cases reported in
the literature have been reviewed.
Case 1
A 92-year-old man presented as an emergency with bleed-
ing per urethra. Multiple painful 2 × 2 cm hard nodules
were seen around the coronal sulcus (PSA = 299 ng/ml).
He had had a primary well-differentiated adenocarci-
noma of the prostate diagnosed 11 years previously. His
treatment included bilateral orchidectomy and cyproter-
one acetate. A clinical diagnosis of penile metastases was
made. In view of the multiple small nodules, urethral
ulceration, local obstructive symptoms and severe penile
pain; surgery was considered instead of external beam
radiotherapy. A subtotal penectomy with perineal ure-
throstomy was performed. The surgery was straightfor-
ward with remarkably little blood loss, probably a result
of genital atrophy secondary to long-term androgen with-
drawal. Histology confirmed the presence of metastatic
moderately well differentiated prostatic adenocarcinoma
(Figure 1) extending through the length of the penis and
into the glans and spreading to the surface of the skin at
the corona with vascular and lymphatic permeation.
There was also urethral ulceration. Immunohistochemis-
try for PSA confirmed histological diagnosis. Pain relief
was rapid with a significant improvement of post-opera-
tive quality of life.
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Case 2
An 85-year-old man was admitted as an emergency with
symptoms of painful urinary outflow obstruction. Trans-
urethral prostatic resection four years previously had
showed a Gleason's Grade 9 prostatic adenocarcinoma;
bilateral orchidectomy was performed, followed by cypro-
terone acetate. Clinical examination revealed palpable
nodular 3 × 1 cm lesions at the penile and bulbar urethra
(PSA = 41.7 ng/ml). Biopsy of these nodules showed sev-
eral malignant glandular structures infiltrating the corpus
cavernosa of the penis suggestive of a poorly differentiated
adenocarcinoma, confirmed immunohistologically (Fig-
ure 2) as of prostatic origin. Suprapubic catheterisation
was followed by immediate pain relief and marked
improvement in quality of life. He is currently receiving
palliative care.
Review of literature
Ninety-eight cases of penile metastases from prostate can-
cer were identified in the literature [3–10]. Patients were
between 42 to 93 years (average 70 years). Urinary symp-
toms were noted in 28 patients, varying in severity from
urethral bleeding to complete urinary retention. Priapism
was reported in half the patients, ten of whom also had
urinary retention. In 16 patients, the presenting symptom
was penile pain; seven of whom had palpable penile nod-
ules. Of 75 patients, metastases was restricted to the cor-
pora cavernosa in 32 patients, glans penis in 12, urethra
in four, skin/prepuce in four and corpus spongiosum in
three and 20 having multiple involved areas. Biopsy was
the mainstay of diagnosis in all the patients with three
having additional cystoscopies. 33 patients underwent
surgery such as penile amputation, cystostomy and bilat-
eral orchidectomy. Fifteen patients each received radia-
tion and hormonal treatment. These patients had a poor
prognosis with survival documented at between 10 days
and 84 months, with an average of 6 months, from
presentation.
Discussion
Metastatic spread from the prostate to the penis occurs by
several routes [7,10], retrograde venous or lymphatic
spread, and direct extension are the commonest mecha-
nisms. The most reliable diagnostic modality remains the
needle core biopsy; this allows for histological and immu-
nological confirmation of metastatic spread, and evalua-
tion of extent of invasion [5]. Treatment options depend
on the general condition of the patient, site and extent of
the primary tumour, presence of metastases, and symp-
tomatology. The treatment options available include local
excision of the tumour, radiation therapy, bilateral
orchidectomy, additional hormonal and/or chemother-
apy and, partial or total amputation of the penis. In
patients who present with urinary tract outflow obstruc-
tion, procedures such as cystostomy or suprapubic cathe-
terisation are of palliative value [7]. Amputation of the
penis with urethrostomy formation is to be considered in
patients with ulceration, irritating secretion and
intractable penile pain for symptom control. In one of our
cases treatment followed palliative lines but in the other,
subtotal penectomy for severe intractable penile pain,
resulted in immediate pain relief and marked
Histology confirms the presence of invasive adenocarcinoma  invading the corpora cavernosa (CC) (15×, H/E) Figure 1
Histology confirms the presence of invasive adenocarcinoma 
invading the corpora cavernosa (CC) (15×, H/E).
Immunohistochemistry shows membrane and luminal positiv- ity for prostatic specific antigen (120×) Figure 2
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ity for prostatic specific antigen (120×).Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/16
Page 3 of 3
(page number not for citation purposes)
improvement in quality of life. Emphasis should be on
palliative treatment and improving quality of life in view
of the poor prognosis and a 6-month mortality of 80%.
Surgery could be a therapeutic option, but only in patients
attended with severe intractable pain.
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